Essam A. Mahmoud

Dr. Essam A. Mahmoud

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2020 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
EMEssam A. Mahmoud
Essam A. Mahmoud
BEBadawi M. El-Sayed
Badawi M. El-Sayed
YMYasser H. Mahsoub
Yasser H. Mahsoub
AEAbd Elhakeem I. El-Murr
Abd Elhakeem I. El-Murr
Ahmed N. F. Neamat-AllahAhmed N. F. Neamat-Allah
Ahmed N. F. Neamat-Allah


1 January 2017 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
RPRajagopalan Prasanna
Rajagopalan Prasanna
EAElbessoumy A. Ashraf
Elbessoumy A. Ashraf
EMEssam A. Mahmoud
Essam A. Mahmoud
The bio-activities of separate Matricaria chamomilla (chamomile) and Origanum vulgare (oregano) are well studied; however, the combined effects of both natural products in animal diabetic models are not well characterized. In this study, alloxan-induced male albino rats were treated with single dose aqueous suspension of chamomile or oregano at dose level of either 150 or 300 mg/kg body mass or as equal parts as combination by stomach tube for 6 weeks. After treatment, blood samples were assessed for diabetic, renal, and lipid profiles. Insulin, amylase activity, and diabetic renal apoptosis were further evaluated. Treatment with higher dose of the extracts (300 mg/kg) as individual or as mixture of low doses (150 mg/kg of both the extracts) had significant mass gain, hypoglycemic effect (p ≤ 0.05) with decreased amylase activity and increased serum insulin levels. Restoration of renal profile, lipid profile with increase in HDL-c (p ≤ 0.05) along with reversal of pro-apoptotic Bax and anti-apoptotic Bcl-2 were well observed with 300 mg/kg mixture, showing synergistic activity of the extracts compared with individual low dose of 150 mg/kg. Collectively, our results indicate that combination of chamomile and oregano extracts will form a new class of drugs to treat diabetic complications.

27 April 2019 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
Ahmed N. F. Neamat-AllahAhmed N. F. Neamat-Allah
Ahmed N. F. Neamat-Allah
EMEssam A. Mahmoud
Essam A. Mahmoud